MiniMed Group, Inc. Common Stock
Minimed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, including insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin t… Read more
MiniMed Group, Inc. Common Stock (MMED) - Total Liabilities
Latest total liabilities as of October 2025: $491.00 Million USD
Based on the latest financial reports, MiniMed Group, Inc. Common Stock (MMED) has total liabilities worth $491.00 Million USD as of October 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
MiniMed Group, Inc. Common Stock - Total Liabilities Trend (2024–2025)
This chart illustrates how MiniMed Group, Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
MiniMed Group, Inc. Common Stock Competitors by Total Liabilities
The table below lists competitors of MiniMed Group, Inc. Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
NATL OILWELL VARCO
MU:NO8
|
Germany | €4.91 Billion |
|
Mahube Infrastructure Ltd
JSE:MHB
|
South Africa | ZAC1.13 Million |
|
Alps Industries Limited
NSE:ALPSINDUS
|
India | ₹9.37 Billion |
|
TELECOM PLUS
BE:T8T
|
Germany | €564.03 Million |
|
ParTec AG
XETRA:JY0
|
Germany | €80.07 Million |
Liability Composition Analysis (2024–2025)
This chart breaks down MiniMed Group, Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.55 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MiniMed Group, Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MiniMed Group, Inc. Common Stock (2024–2025)
The table below shows the annual total liabilities of MiniMed Group, Inc. Common Stock from 2024 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-04-30 | $870.00 Million | +34.67% |
| 2024-04-30 | $646.00 Million | -- |